Maywufa Company Ltd. (TPE:1731)
Taiwan · Delayed Price · Currency is TWD 21.00
+0.05 (0.24%)
Sep 8, 2026, 1:30 PM CST
Maywufa Company Market Cap
Maywufa Company has a market cap or net worth of 2.79 billion as of September 8, 2026. Its market cap has decreased by -4.76% in one year.
Market Cap
2.79B
Enterprise Value
2.68B
Revenue
1.64B
Ranking
n/a
PE Ratio
13.91
Stock Price
21.00
ChartMarket Cap Chart
Since September 19, 2001, Maywufa Company's market cap has increased from 781.98M to 2.79B, an increase of 256.94%. That is a compound annual growth rate of 5.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 2.79B | -3.45% |
| Dec 31, 2025 | 2.89B | -5.02% |
| Dec 31, 2024 | 3.04B | 2.00% |
| Dec 29, 2023 | 2.98B | 13.67% |
| Dec 30, 2022 | 2.63B | 1.02% |
| Dec 30, 2021 | 2.60B | 12.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Panion & Bf Biotech | 4.83B |
| Yoda Pharmaceuticals | 4.57B |
| LIWANLI Innovation | 4.45B |
| Orient EuroPharma | 3.96B |
| Easywell Biomedicals | 3.70B |
| Tien Liang BioTech | 2.81B |
| Allied Biotech | 2.66B |
| Merdury Biopharmaceutical | 2.35B |